Literature DB >> 18263696

Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis.

Zhongsheng Peng1, Patricia Fernandez, Tuere Wilder, Herman Yee, Luis Chiriboga, Edwin S L Chan, Bruce N Cronstein.   

Abstract

Adenosine is a potent endogenous regulator of tissue repair that is released from injured cells and tissues. Hepatic fibrosis results from chronic hepatic injury, and we have previously reported that endogenously generated adenosine, acting at A(2A) receptors, plays a role in toxin-induced hepatic fibrosis. Adenosine may form intracellularly and then be transported to the extracellular space or it may form extracellularly from adenine nucleotides released from injured cells. Because ecto-5'-nucleotidase (CD73) catalyzes the terminal step in extracellular adenosine formation from AMP, we determined whether CD73 plays a role in the development of hepatic fibrosis. Mice were treated overnight with PBS, CCl(4), ethanol, or thioacetamide (TAA); their livers were harvested, and slices were incubated in medium for 20 h before adenosine concentration in the supernatant was measured by HPLC. Hepatic fibrosis was induced by CCl(4) or TAA treatment in CD73 knockout (CD73KO and C57BL/6 background) and C57BL/6 control mice [wild-type (WT)] mice and quantified by digital analysis of picrosirius red stained slides and hydroxyproline content. mRNA expression was quantified by real-time polymerase chain reaction, and protein was quantified by Western blot or enzyme-linked immunosorbent assay. Livers from WT mice treated with CCl(4), ethanol, and TAA released 2- to 3-fold higher levels of adenosine than livers from comparably treated CD73KO mice. CD73KO mice were protected from fibrosis with significantly less collagen content in the livers of CD73KO than WT mice after treatment with either CCl(4) or TAA. There were far fewer alpha-smooth muscle actin positive hepatic stellate cells in CCl(4)-treated KO mice than that in WT mice. After CCl(4) treatment, the mRNA level of A(1), A(2A), A(2B), and A(3) adenosine receptors, tumor necrosis factor-alpha, interleukin (IL) -1beta, IL-13r alpha1, matrix metalloproteinase (MMP)-2, MMP-14, tissue inhibitor of metalloproteinase (TIMP) -1, and TIMP-2, and IL-13 level increased markedly in both CD73KO and WT mice, but Col1 alpha1, Col3 alpha1, and transforming growth factor-beta1 mRNA increased much more in WT mice than that in KO mice. Moreover, IL-13r alpha2, MMP-13 mRNA, and MMP-13 protein were higher in KO mice than that in WT mice. These results indicate that adenosine, formed extracellularly from adenine nucleotides, plays a major role in the pathogenesis of hepatic fibrosis and that inhibition of adenosine production or blockade of adenosine receptors may help prevent hepatic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263696     DOI: 10.1096/fj.07-100685

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.

Authors:  Michel Fausther; Joanna Lecka; Elwy Soliman; Gilles Kauffenstein; Julie Pelletier; Nina Sheung; Jonathan A Dranoff; Jean Sévigny
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-01       Impact factor: 4.052

2.  New Approaches for Studying Alcoholic Liver Disease.

Authors:  Jun Xu; Xiao Liu; Bin Gao; Michael Karin; Hidekazu Tsukamoto; David Brenner; Tatiana Kisseleva
Journal:  Curr Pathobiol Rep       Date:  2014-09-14

3.  Variable penetrance of metabolic phenotypes and development of high-fat diet-induced adiposity in NEIL1-deficient mice.

Authors:  Harini Sampath; Ayesha K Batra; Vladimir Vartanian; J Russ Carmical; Deborah Prusak; Irena B King; Brian Lowell; Lauriel F Earley; Thomas G Wood; Daniel L Marks; Amanda K McCullough; Lloyd R Stephen
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-01       Impact factor: 4.310

4.  Adenosine A2A receptors play an active role in mouse bone marrow-derived mesenchymal stem cell development.

Authors:  Majid Katebi; Mansooreh Soleimani; Bruce N Cronstein
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

5.  TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

6.  Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3.

Authors:  Miguel Perez-Aso; Patricia Fernandez; Aránzazu Mediero; Edwin S Chan; Bruce N Cronstein
Journal:  FASEB J       Date:  2013-11-07       Impact factor: 5.191

7.  An Elf2-like transcription factor acts as repressor of the mouse ecto-5'-nucleotidase gene expression in hepatic myofibroblasts.

Authors:  Michel Fausther; Elise G Lavoie; Jessica R Goree; Jonathan A Dranoff
Journal:  Purinergic Signal       Date:  2017-06-30       Impact factor: 3.765

Review 8.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

Authors:  Marquet Minor; Karel P Alcedo; Rachel A Battaglia; Natasha T Snider
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

9.  Adenosine A2a Receptor Blockade Diminishes Wnt/β-Catenin Signaling in a Murine Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Jin Zhang; Carmen Corciulo; Hailing Liu; Tuere Wilder; Mayumi Ito; Bruce Cronstein
Journal:  Am J Pathol       Date:  2017-06-28       Impact factor: 4.307

10.  Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis.

Authors:  Florian Wirsdörfer; Simone de Leve; Federica Cappuccini; Therese Eldh; Alina V Meyer; Eva Gau; Linda F Thompson; Ning-Yuan Chen; Harry Karmouty-Quintana; Ute Fischer; Michael Kasper; Diana Klein; Jerry W Ritchey; Michael R Blackburn; Astrid M Westendorf; Martin Stuschke; Verena Jendrossek
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.